Rein Willemze
Emeritus hoogleraar Huid- en geslachtsziekten
- Naam
- Prof.dr. R. Willemze
- Telefoon
- +31 71 526 2421
- willemze.dermatology@lumc.nl
- ORCID iD
- null
Emeritus hoogleraar Huid- en geslachtsziekten
- Faculteit Geneeskunde
- Divisie 3
- Huidziekten
- Ottevanger, R.; Beugen, S. van; Evers, A.W.M.; Willemze, R.; Vermeer, M.H. & Quint, K.D. (2023), Quality of life in cutaneous T-cell lymphoma patients receiving mogamulizumab, Cancers 15(1).
- Pagano, L.; Zinzani, P.L.; Pileri, S.; Quaglino, P.; Cuglievan, B.; Berti, E.; Pemmaraju, N.; Onida, F.; Willemze, R.; Orfao, A. & Barosi, G. (2023), Unmet clinical needs and management recommendations for blastic plasmacytoid dendritic cell neoplasm, HemaSphere 7(3).
- Hodak, E.; Geskin, L.; Guenova, E.; Ortiz-Romero, P.L.; Willemze, R.; Zheng, J.; Cowan, R.; Foss, F.; Mangas, C. & Querfeld, C. (2023), Real-life barriers to diagnosis of early mycosis fungoides, American Journal of Clinical Dermatology 24(3): 493-493.
-
Latzka, J.; Assaf, C.; Bagot, M.; Cozzio, A.; Dummer, R.; Guenova, E.; Gniadecki, R.; Hodak, E.; Jonak, C.; Klemke, C.D.; Knobler, R.; Morrris, S.; Nicolay, J.P.; Ortiz-Romero, P.L.; Papadavid, E.; Pimpinelli, N.; Quaglino, P.; Ranki, A.; Scarisbrick, J.; Stadler, R.; Väkevä, L.; Vermeer, M.H.; Wehkamp, U.; Whittaker, S.; Willemze, R. & Trautinger, F. (2023), EORTC consensus recommendations for the treatment of mycosis fungoides/S
ezary syndrome - Update 2023, European Journal of Cancer 195. - Schrader, A.M.R.; Groen, R.A.L. de; Willemze, R.; Jansen, P.M.; Quint, K.D.; Wezel, T. van; Eijk, R. van; Ruano, D.; Tensen, C.P.; Hauben, E.; Woei-A-Jin, F.J.S.H.; Busschots, A.M.; Berg, A. van den; Diepstra, A.; Vermeer, M.H. & Vermaat, J.S.P. (2022), Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas, Virchows Archiv 480.
- Ottevanger, R.; Beugen, S. van; Evers, A.W.M.; Willemze, R.; Vermeer, M.H. & Quint, K.D. (2022), Itch as a quality of life indicator in patients with cutaneous T cell lymphoma, European Journal of Cancer 173: S39-S39.
- Ottevanger, R.; Bruin, D. de; Willemze, R.; Jansen, P.; Bekkenk, M.; Haas, E. de; Horvath, B.; Rossum, M. van; Sanders, C.; Veraart, J.; Vermeer, M. & Quint, K. (2021), Incidence of mycosis fungoides and Sezary syndrome in the Netherlands in the last two decades, European Journal of Cancer 156: S32-S32.
- Ottevanger, R.; deBruin, D.T.; Willemze, R.; Jansen, P.M.; Bekkenk, M.W.; deHaas, E.R.M.; Horvath, B.; vanRossum, M.M.; Sanders, C.J.G.; Veraart, J.C.J.M.; Vermeer, M.H. & Quint, K.D. (2021), Incidence of mycosis fungoides and Sezary syndrome in the Netherlands between 2000 and 2020.
- Schrader, A.M.R.; Groen, R.A.L. de; Willemze, R.; Jansen, P.M.; Quint, K.D.; Wezel, T. van; Eijk, R. van; Ruano, D.; Diepstra, A.; Berg, A. van den; Kakiailatu, N.; Vermeer, M.H. & Vermaat, J.S.P. (2021), Clues for disease progression at time of diagnosis in patients with primary cutaneous follicle center lymphoma, European Journal of Cancer 156: S9-S10.
- Ottevanger, R.; Beugen, S. van; Evers, A.; Willemze, R.; Vermeer, M. & Quint, K. (2021), Quality of life in patients with mycosis fungoides and Sezary syndrome: a review of the literature, European Journal of Cancer 156: S65-S65.
- Quaglino, P.; Ortiz-Romero, P.; Bagot, M.; Cozzio, A.; Evison, F.; Geskin, L.; Guenova, E.; Hodak, E.; Horwitz, S.; Papadavid, E.; Porcu, P.; Prince, M.; Stadler, R.; Vermeer, M.; Willemze, R.; Zinzani, P.; Whittaker, S.; Cowan, R.; Kim, Y.J. & Scarisbrick, J.J. (2021), Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry, European Journal of Cancer 156: S28-S28.
- Quaglino, P.; Prince, H.M.; Cowan, R.; Vermeer, M.; Papadavid, E.; Bagot, M.; Servitjie, O.; Berti, E.; Guenova, E.; Stadler, R.; Querfeld, C.; Busschots, A.M.; Hodak, E.; Patsatsi, A.; Sanches, J.; Maule, M.; Yoo, J.; Kevin, M.; Fava, P.; Ribero, S.; Zocchi, L.; Rubatto, M.; Fierro, M.T.; Wehkamp, U.; Marshalko, M.; Mitteldorf, C.; Akilov, O.; Ortiz-Romero, P.; Estrach, T.; Vakeva, L.; Enz, P.A.; Wobser, M.; Bayne, M.; Jonak, C.; Rubeta, M.; Forbes, A.; Bates, A.; Battistella, M.; Amel-Kashipaz, R.; Vydianath, B.; Combalia, A.; Georgiou, E.; Hauben, E.; Hong, E.K.; Jost, M.; Knobler, R.; Amitay-Laish, I.; Miyashiro, D.; Cury-Martins, J.; Martinez, X.; Muniesa, C.; Prag-Naveh, H.; Stratigos, A.; Nikolaou, V.; Quint, K.; Ram-Wolff, C.; Rieger, K.; Stranzenbach, R.; Szepesi, A.; Alberti-Violetti, S.; Felicity, E.; Cerroni, L.; Kempf, W.; Whittaker, S.; Willemze, R.; Kim, Y. & Scarisbrick, J.J. (2021), Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study, British Journal of Dermatology 184(4): 722-730.
- Ottevanger, R.; Beugen, S.; Evers, A.W.M.; Willemze, R.; Vermeer, M.H. & Quint, K.D. (2021), Quality of life in patients with Mycosis Fungoides and Sezary Syndrome: a systematic review of the literature, Journal of the European Academy of Dermatology and Venereology 35(12): 2377-2387.
- Kempf, W.; Mitteldorf, C.; Battistella, M.; Willemze, R.; Cerroni, L.; Santucci, M.; Geissinger, E.; Jansen, P.; Vermeer, M.H.; Marschalko, M.; Papadavid, E.; Piris, M.A.; Ortiz-Romero, P.L.; Novelli, M.; Paulli, M.; Quaglino, P.; Ranki, A.; Peralto, J.L.R.; Wobser, M.; Auschra, B. & Robson, A. (2021), Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features, Journal of the European Academy of Dermatology and Venereology 35(3): 658-668.
- Suzanne van Santen, Willem H. Zoutman, Adèle de Masson, Koen D. Quint, Rein Willemze, Nega Gerard, Jessica E. Teague, Thomas S. Kupper, Rachael A. Clark, Cornelis P. Tensen & Maarten H. Vermeer (2021), Tumor clone frequency calculation using high throughput sequencing of the T-cell receptor β gene in folliculotropic mycosis fungoides patients, Journal of Investigative Dermatology.
- Santen, S. van; Out, J.J.; Zoutman, W.H.; Quint, K.D.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2021), Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants, BIOCHEMISTRY AND BIOPHYSICS REPORTS 26.
- Melchers, R.C.; Willemze, R.; Loo, M. van de; Doorn, R. van; Jansen, P.M.; Cleven, A.H.G.; Solleveld, N.; Bekkenk, M.W.; Kester, M.S. van; Diercks, G.F.H.; Vermeer, M.H. & Quint, K.D. (2020), Clinical, histologic, and molecular characteristics of anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma, The American Journal of Surgical Pathology 44(6): 776-781.
- Torres, A.N.B.; Cats, D.; Mei, H.L.; Fanoni, D.; Gliozzo, J.; Corti, L.; Paulli, M.; Vermeer, M.H.; Willemze, R.; Berti, E. & Tensen, C.P. (2020), Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm, Genes, Chromosomes and Cancer 59(5): 295-308.
- Melchers, R.C.; Willemze, R.; Vermaat, J.S.P.; Jansen, P.M.; Daniels, L.A.; Putter, H.; Bekkenk, M.W.; Haas, E.R.M. de; Horvath, B.; Rossum, M.M. van; Sanders, C.J.G.; Veraart, J.C.J.M.; Vermeer, M.H. & Quint, K.D. (2020), Outcomes of rare patients with a primary cutaneous CD30(+) lymphoproliferative disorder developing extracutaneous disease.
- Deenen, N.J.; Koens, L.; Jaspars, E.H.; Vermeer, M.H.; Willemze, R.; Rie, M.A. de & Bekkenk, M.W. (2019), Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8(+) T-cell lymphoma, British Journal of Dermatology 180(2): 411-412.
- Koning, M.T.; Quinten, E.; Zoutman, W.H.; Kielbasa, S.M.; Mei, H.L.; Bergen, C.A.M. van; Jansen, P.; Vergroesen, R.D.; Willemze, R.; Vermeer, M.H.; Tensen, C.P. & Veelken, H. (2019), Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire, Journal of Investigative Dermatology 139(10): 2195-2203.
- Melchers Rutger, Willemze Rein, Quint Koen, Vermeer Maarten, Bekkenk Marcel, de Haas Ellen, Horvath Barbara, van Rossum Michelle, Sanders Cornelus & Veraart Joep (2018), Frequency of associated haematologic malignancies in lymphomatoid papulosis: A preliminary report of 505 patients from the Dutch Cutaneous Lymphoma Group, European Journal of Cancer 101: S6-S6.
- Koning Marvyn T., Quinten Edwin, Zoutman Willem H., van der Zeeuw Sander A. J., Kielbasa Szymon M., Mei Hailang, van Bergen Cornelis A. M., Jansen Patty M., Willemze Rein, Schmidt Christian, Vermeer Maarten, Tensen Cornelis P. & Veelken Hendrik (2018), Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N Glycosylation Motifs and Lack Ongoing Somatic Hypermutation, Blood 132.
- Schrader, A.M.R.; Jansen, P.M.; Willemze, R.; Vermeer, M.H.; Cleton-Jansen, A.M.; Somers, S.F.; Veelken, H.; Eijk, R. van; Kraan, W.; Kersten, M.J.; Brand, M. van den; Stevens, W.B.C.; Jong, D. de; Hamid, M.A.; Tanis, B.C.; Posthuma, E.F.M.; Nijland, M.; Diepstra, A.; Pals, S.T.; Cleven, A.H.G. & Vermaat, J.S.P. (2018), High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma, Blood 131(18): 2086-2089.
- Willemze Rein (2018), Primary cutaneous anaplastic large cell lymphoma and other cutaneous T-cell lymphomas in children and adolescents, British Journal of Haematology 182: 27-27.
- Willemze, R. (2018), Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment, Seminars in Cutaneous Medicine and Surgery 37(1): 11-17.
- Gru, A.A.; Kim, J.; Pulitzer, M.; Guitart, J.; Battistella, M.; Wood, G.S.; Cerroni, L.; Kempf, W.; Willemze, R.; Pawade, J.; Querfeld, C.; Schaffer, A.; Pincus, L.; Tetzlaff, M.; Duvic, M.; Scarisbrick, J.; Porcu, P.; Mangold, A.R.; DiCaudo, D.J.; Shinohara, M.; Hong, E.K.; Horton, B. & Kim, Y.H. (2018), The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sezary Syndrome A Multi-institutional and International Pathology Study, American Journal of Surgical Pathology 42(6): 726-734.
- Fanoni, D.; Corti, L.; Alberti-Violetti, S.; Tensen, C.P.; Venegoni, L.; Vermeer, M.; Willemze, R. & Berti, E. (2018), Array-based CGH of primary cutaneous CD8+aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma, Genes, Chromosomes and Cancer 57(12): 622-629.
- Baron, F.; Stevens-Kroef, M.; Kicinski, M.; Meloni, G.; Muus, P.; Marie, J.P.; Halkes, C.J.M.; Thomas, X.; Vrhovac, R.; Specchia, G.; Lefrere, F.; Sica, S.; Mancini, M.; Venditti, A.; Hagemeijer, A.; Becker, H.; Jansen, J.H.; Amadori, S.; Witte, T. de; Willemze, R. & Suciu, S. (2018), Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials, Annals of Hematology 97(10): 1785-1795.
- Melchers, R.C.; Willemze, R.; Bekkenk, M.W.; Haas, E.R.M. de; Horvath, B.; Rossum, M.M. van; Sanders, C.J.G.; Veraart, J.C.J.M.; Vermeer, M.H. & Quint, K.D. (2018), Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
- Torres Armando Bastidas, Cats Davy, Mei Hailiang, Szuhai Karoly, Willemze Rein, Vermeer Maarten & Tensen Cornelis (2018), Genomic analysis reveals recurrent deletion of HNRNPK and SOCS1 in mycosis fungoides, European Journal of Cancer 101: S7-S7.
- Torres, A.N.B.; Cats, D.; Mei, H.L.; Szuhai, K.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2018), Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides, Genes, Chromosomes and Cancer 57(12): 653-664.
- Schrader, A.M.R.; Jansen, P.M.; Vermeer, M.H.; Kleiverda, J.K.; Vermaat, J.S.P. & Willemze, R. (2018), High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, American Journal of Surgical Pathology 42(11): 1488-1494.
- Santen, S. van; Vermeer, M.H. & Willemze, R. (2018), Classification and recommended treatment options for folliculotropic mycosis fungoides, Expert Opinion on Orphan Drugs 6(1): 35-45.
- Santen, S. van; Jansen, P.M.; Vermeer, M.H. & Willemze, R. (2018), Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases, Journal of Cutaneous Pathology 45(2): 122-128.
- Scarisbrick J., Quaglino P., Vermeer M., Prince H., Papadavid E., Hodak E., Whittaker S., Bagot M., Ortiz P., Stadler R., Knobler R., Evison F., Hong E., Willemze R. & Kim Y. H. (2018), Global collaboration for establishment of a prognostic index in mycosis fungoides & Sezary Syndrome, Journal of Investigative Dermatology 138(5): S88-S88.
- Quaglino, P.; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; Papadavid, E.; Sanches, J.A.; Hodak, E.; Sugaya, M.; Berti, E.; Ortiz-Romero, P.; Pimpinelli, N.; Servitje, O.; Pileri, A.; Zinzani, P.L.; Estrach, T.; Knobler, R.; Stadler, R.; Fierro, M.T.; Violetti, S.A.; Amitay-Laish, I.; Antoniou, C.; Astrua, C.; Chaganti, S.; Child, F.; Combalia, A.; Fabbro, S.; Fava, P.; Grandi, V.; Jonak, C.; Martinez-Escala, E.; Kheterpal, M.; Kim, E.J.; McCormack, C.; Miyagaki, T.; Miyashiro, D.; Morris, S.; Muniesa, C.; Nikolaou, V.; Ognibene, G.; Onida, F.; Osella-Abate, S.; Porkert, S.; Postigo-Llorente, C.; Ram-Wolff, C.; Ribero, S.; Rogers, K.; Sanlorenzo, M.; Stranzenbach, R.; Spaccarelli, N.; Stevens, A.; Zugna, D.; Rook, A.H.; Geskin, L.J.; Willemze, R.; Whittaker, S.; Hoppe, R.; Scarisbrick, J. & Kim, Y. (2017), Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium, Annals of Oncology 28(10): 2517-2525.
- Melchers, R.C.; Willemze, R.; Daniels, L.A.; Neelis, K.J.; Bekkenk, M.W.; Haas, E.R.M. de; Horvath, B.; Rossum, M.M. van; Sanders, C.J.G.; Velstra, B.; Veraart, J.C.J.M.; Roach, R.E.J.; Vermeer, M.H. & Quint, K.D. (2017), Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group, International Journal of Radiation Oncology - Biology - Physics 99(5): 1279-1285.
- Santen, S. van; Doorn, R. van; Neelis, K.J.; Daniels, L.A.; Horvath, B.; Bruijn, M.S.; Sanders, C.J.G.; Rossum, M.M. van; Haas, E.R.M. de; Veraart, J.C.J.M.; Bekkenk, M.W.; Vermeer, M.H. & Willemze, R. (2017), Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group, British Journal of Dermatology 177(1): 223-228.
- Genders, R.E.; Beck, S.; Bavinck, J.N.B.; Munckhof, H.A.M. van den; Kouwenhoven, S.T.P.; Koning, M.N.C. de; Gruijl, F.R. de; Jenkins, D.; Willemze, R. & Quint, K.D. (2017), p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern, Journal of Cutaneous Pathology 44(1): 28-33.
- Schrader, A.M.R.; Jansen, P.M. & Willemze, R. (2016), TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4+CD8- phenotype, British Journal of Dermatology 175.
- Cetinozman, F.; Jansen, P. & Willemze, R. (2016), Clear cell acanthoma on the dorsum of the hand, Journal of the European Academy of Dermatology and Venereology 30(2): 378-380.
- Bakar, O.; Sahin, S.; Cetinozman, F.; Willemze, R.; Tezcanli, E. & Cetin, E.D. (2015), Tumor-stage mycosis fungoides of the vulva successfully treated with local low-dose radiotherapy, Dermatologic Therapy 28(1): 36-39.
- Bruijn, M.S.; Horvath, B.; Vader, P.C.V.; Willemze, R. & Vermeer, M.H. (2015), Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group, British Journal of Dermatology 173(5): 1319-1322.
- Vermeer, M.H. & Willemze, R. (2015), Limited effect of chemotherapy in cutaneous lymphoma, Blood 125(1): 4-5.
- Klemke, C.D.; Booken, N.; Weiss, C.; Nicolay, J.P.; Goerdt, S.; Felcht, M.; Geraud, C.; Kempf, W.; Assaf, C.; Ortonne, N.; Battistella, M.; Bagot, M.; Knobler, R.; Quaglino, P.; Arheiliger, B.; Santucci, M.; Jansen, P.; Vermeer, M.H. & Willemze, R. (2015), Histopathological and immunophenotypical criteria for the diagnosis of Sezary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases, British Journal of Dermatology 173(1): 93-105.
- Boonk, S.E.; Cetinozman, F.; Vermeer, M.H.; Jansen, P.M. & Willemze, R. (2015), Differential expression of TOX by skin-infiltrating T cells in Sezary syndrome and erythrodermic dermatitis, Journal of Cutaneous Pathology 42(9): 604-609.
- Nicolae-Cristea, A.R.; Benner, M.F.; Zoutman, W.H.; Eijk, R. van; Jansen, P.M.; Tensen, C.P. & Willemze, R. (2015), Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease, British Journal of Dermatology 172(3): 784-788.
- Scarisbrick, J.J.; Prince, H.M.; Vermeer, M.H.; Quaglino, P.; Horwitz, S.; Porcu, P.; Stadler, R.; Wood, G.S.; Beylot-Barry, M.; Pham-Ledard, A.; Foss, F.; Girardi, M.; Bagot, M.; Michel, L.; Battistella, M.; Guitart, J.; Kuzel, T.M.; Martinez-Escala, M.E.; Estrach, T.; Papadavid, E.; Antoniou, C.; Rigopoulos, D.; Nikolaou, V.; Sugaya, M.; Miyagaki, T.; Gniadecki, R.; Sanches, J.A.; Cury-Martins, J.; Miyashiro, D.; Servitje, O.; Muniesa, C.; Berti, E.; Onida, F.; Corti, L.; Hodak, E.; Amitay-Laish, I.; Ortiz-Romero, P.L.; Rodriguez-Peralto, J.L.; Knobler, R.; Porkert, S.; Bauer, W.; Pimpinelli, N.; Grandi, V.; Cowan, R.; Rook, A.; Kim, E.; Pileri, A.; Patrizi, A.; Pujol, R.M.; Wong, H.; Tyler, K.; Stranzenbach, R.; Querfeld, C.; Fava, P.; Maule, M.; Willemze, R.; Evison, F.; Morris, S.; Twigger, R.; Talpur, R.; Kim, J.; Ognibene, G.; Li, S.F.; Tavallaee, M.; Hoppe, R.T.; Duvic, M.; Whittaker, S.J. & Kim, Y.H. (2015), Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model, Journal of Clinical Oncology 33(32): 3766-+.
- Robson, A.; Assaf, C.; Bagot, M.; Burg, G.; Calonje, E.; Castillo, C.; Cerroni, L.; Chimenti, N.; Dechelotte, P.; Franck, F.; Geerts, M.; Gellrich, S.; Goodlad, J.; Kempf, W.; Knobler, R.; Massone, C.; Meijer, C.; Ortiz, P.; Petrella, T.; Pimpinelli, N.; Roewert, J.; Russell-Jones, R.; Santucci, M.; Steinhoff, M.; Sterry, W.; Wechsler, J.; Whittaker, S.; Willemze, R. & Berti, E. (2015), Aggressive epidermotropic cutaneous CD8(+) lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop, Histopathology 67(4): 425-441.
- Cetinozman, F.; Jansen, P.M. & Willemze, R. (2014), Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma, British Journal of Dermatology 171(3): 499-504.
- Cetinozman, F.; Koens, L.; Jansen, P.M. & Willemze, R. (2014), Programmed death-1 expression in cutaneous B-cell lymphoma, Journal of Cutaneous Pathology 41(1): 14-21.
- Koens, L.; Zoutman, W.H.; Ngarmlertsirichai, P.; Przybylski, G.K.; Grabarczyk, P.; Vermeer, M.H.; Willemze, R.; Jansen, P.M.; Schmidt, C.A. & Tensen, C.P. (2014), Nuclear Factor-kappa B Pathway-Activating Gene Aberrancies in Primary Cutaneous Large B-Cell Lymphoma, Leg Type, Journal of Investigative Dermatology 134(1): 290-292.
- Boonk, S.E.; Putter, H.; Koolhof, L.; Willemze, R. & Vermeer, M.H. (2014), Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides, British Journal of Dermatology 170(5): 1080-1086.
- Vermeer, M.H. & Willemze, R. (2014), Recent advances in primary cutaneous B-cell lymphomas, Current Opinion in Oncology 26(2): 230-236.
- Koens, L.; Senff, N.J.; Vermeer, M.H.; Willemze, R. & Jansen, P.M. (2014), Methotrexate-associated B-cell Lymphoproliferative Disorders Presenting in the Skin A Clinicopathologic and Immunophenotypical Study of 10 Cases, American Journal of Surgical Pathology 38(7): 999-1006.
- Franken, S.M.; Genders, R.E.; Gruijl, F.R. de; Rustemeyer, T. & Pavel, S. (2013), Skin hardening effect in patients with polymorphic light eruption: Comparison of UVB hardening in hospital with a novel home UV-hardening device., Journal of the European Academy of Dermatology and Venereology 27(1): 67-72.
- Gao, L.; Smit, M.A.; Oord, J.J. van den; Goeman, J.J.; Verdegaal, E.M.E.; Burg, S.H. van der; Stas, M.; Beck, S.; Gruis, N.A.; Tensen, C.P.; Willemze, R.; Peeper, D.S. & Doorn, R. van (2013), Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma, Pigment Cell and Melanoma Research 26(4).
- Gao, L.; Smit, M.; Oord, J. van den; Goeman, J.; Verdegaal, E.; Burg, S. van der; Stas, M.; Beck, S.; Gruis, N.; Tensen, C.; Willemze, R.; Peeper, D. & Doorn, R. van (2013), Comprehensive promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma, Journal of Investigative Dermatology 133: S228-S228.
- Janson, D.; Rietveld, M.; Willemze, R. & Ghalbzouri, A. el (2013), Effects of serially passaged fibroblasts on dermal and epidermal morphogenesis in human skin equivalents, Biogerontology 14(2): 131-140.
- Fanoni, D.; Tensen, C.P.; Novara, F.; Venegoni, L.; Corti, L.; Violetti, S.A.; Onida, F.; Paulli, M.; Willemze, R. & Berti, E. (2013), Molecular analysis of primary cutaneous aggressive T-cell lymphomas, Journal of Investigative Dermatology 133: S70-S70.
- Swerdlow, S.H.; Quintanilla-Martinez, L.; Willemze, R. & Kinney, M.C. (2013), Cutaneous B-Cell Lymphoproliferative Disorders Report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop, American Journal of Clinical Pathology 139(4): 515-535.
- Vermeer, M.; Bagot, M.; Whittaker, S.; Willemze, R.; Boonk, S.; Zoutman, W.; Tensen, K. & Fits, L. van der (2013), Diagnostic markers for Sezary syndrome, Journal of Investigative Dermatology 133: S60-S60.
- Koens, L.; Qin, Y.J.; Leung, W.Y.; Corver, W.E.; Jansen, P.M.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2013), MicroRNA Profiling of Primary Cutaneous Large B-Cell Lymphomas, PLoS ONE 8(12).
- Sarantopoulos, G.P.; Palla, B.; Said, J.; Kinney, M.C.; Swerdlow, S.M.; Willemze, R. & Binder, S.W. (2013), Mimics of Cutaneous Lymphoma Report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop, American Journal of Clinical Pathology 139(4): 536-551.
- Hameetman, L.; Commandeur, S.; Bavinck, J.N.B.; Wisgerhof, H.C.; Gruijl, F.R. de; Willemze, R.; Mullenders, L.; Tensen, C.P. & Vrieling, H. (2013), Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients, BMC Cancer 13.
- Song, S.X.; Willemze, R.; Swerdlow, S.H.; Kinney, M.C. & Said, J.W. (2013), Mycosis Fungoides Report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop, American Journal of Clinical Pathology 139(4): 466-490.
- Quintanilla-Martinez, L.; Jansen, P.M.; Kinney, M.C.; Swerdlow, S.H. & Willemze, R. (2013), Non-Mycosis Fungoides Cutaneous T-Cell Lymphomas Report of the 2011 Society for Hematopathology/European Association for Haematopathology Workshop, American Journal of Clinical Pathology 139(4): 491-514.
- Hogewoning, A.; Amoah, A.; Bavinck, J.N.B.; Boakye, D.; Yazdanbakhsh, M.; Adegnika, A.; Smedt, S. de; Fonteyne, Y.; Willemze, R. & Lavrijsen, A. (2013), Skin diseases among schoolchildren in Ghana, Gabon, and Rwanda, International Journal of Dermatology 52(5): 589-600.
- Voskamp, P.; Bodmann, C.A.; Koehl, G.E.; Tensen, C.P.; Bavinck, J.N.B.; Willemze, R.; Geissler, E.K. & Gruijl, F.R. de (2013), No Acceleration of UV-Induced Skin Carcinogenesis from Evenly Spread Dietary Intake of Cyclosporine in Contrast to Oral Bolus Dosages, Transplantation 96(10): 871-876.
- Qin, Y.J.; Buermans, H.P.J.; Kester, M.S. van; Fits, L. van der; Out-Luiting, J.J.; Osanto, S.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2012), Deep-Sequencing Analysis Reveals that the miR-199a2/214 Cluster within DNM3os Represents the Vast Majority of Aberrantly Expressed MicroRNAs in Sezary Syndrome, Journal of Investigative Dermatology 132(5): 1520-1522.
- Kester, M.S. van; Leung, W.Y.; Borg, M.K.; Zoutman, W.H.; Out-Luiting, J.J.; Jansen, P.M.; Vermeer, M.H.; Willemze, R.; Doorn, R. van & Tensen, C.P. (2012), A Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides, Journal of Investigative Dermatology 132: S38-S38.
- Wisgerhof, H.C.; Wolterbeek, R.; Haasnoot, G.W.; Claas, F.H.J.; Fijter, J.W. de; Willemze, R. & Bavinck, J.N.B. (2012), The risk of cancer is not increased in patients with multiple kidney transplantations., Transplant Immunology 27(4): 189-94.
- Edelbroek, J.R.; Vermeer, M.H.; Jansen, P.M.; Stoof, T.J.; Linden, M.M.D. van der; Horvath, B.; Baarlen, J. van & Willemze, R. (2012), Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.
- Willemze, R. (2012), Thirty years of progress in cutaneous lymphoma research., Giornale Italiano di Dermatologia e Venereologia 147(6): 515-21.
- Rietveld, M.; Janson, D.; Siamari, R.; Vicanova, J.; Andersen, M.T. & Ghalbzouri, A. el (2012), Marine-derived nutrient improves epidermal and dermal structure and prolongs the life span of reconstructed human skin equivalents., Journal of Cosmetic Dermatology 11(3): 213-22.
- Genders, R.E.; Hamminga, E.A. & Kukutsch, N.A. (2012), Securing the subcuticular running suture., Dermatologic Surgery 38(10): 1722-4.
- Kester, M.S. van; Borg, M.K.; Zoutman, W.H.; Out-Luiting, J.J.; Jansen, P.M.; Dreef, E.J.; Vermeer, M.H.; Doorn, R. van; Willemze, R. & Tensen, C.P. (2012), A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
- Cetinozman, F.; Jansen, P.M. & Willemze, R. (2012), Expression of Programmed Death-1 in Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma, Cutaneous Pseudo-T-Cell Lymphoma, and Other Types of Cutaneous T-Cell Lymphoma, American Journal of Surgical Pathology 36(1): 109-116.
- Voskamp, P.; Bodmann, C.A.; Rebel, H.G.; Koehl, G.E.; Tensen, C.P.; Bavinck, J.N.B.; Ghalbzouri, A. el; Kranen, H.J. van; Willemze, R.; Geissler, E.K. & Gruijl, F.R. de (2012), Rapamycin impairs UV induction of mutant-p53 overexpressing cell clusters without affecting tumor onset., International Journal of Cancer 131(6): 1267-76.
- Wisgerhof, H.C.; Wolterbeek, R.; Fijter, J.W. de; Willemze, R. & Bavinck, J.N.B. (2012), Kidney transplant recipients with cutaneous squamous cell carcinoma have an increased risk of internal malignancy.
- Commandeur, S.; Drongelen, V. van; Gruijl, F.R. de & Ghalbzouri, A. el (2012), Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma., Cancer Science 103(12): 2120-6.
- Benner, M.F.; Ballabio, E.; Kester, M.S. van; Saunders, N.J.; Vermeer, M.H.; Willemze, R.; Lawrie, C.H. & Tensen, C.P. (2012), Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides, Experimental Dermatology 21(8): 632-634.
- Gao, L.; Nieuwpoort, F.A. van; Out, J.J.; Hensbergen, P.J.; Snoo, F.A. de; Bergman, W.; Doorn, R. van & Gruis, N.A. (2012), Genome-wide analysis of gene and protein expression of dysplastic naevus cells., Journal of Skin Cancer 2012: 981308.
- Janson, D.G.; Saintigny, G.; Adrichem, A. van; Mahe, C. & Ghalbzouri, A. el (2012), Different gene expression patterns in human papillary and reticular fibroblasts.
- Cetinozman, F.; Jansen, P.M.; Vermeer, M.H. & Willemze, R. (2012), Differential Expression of Programmed Death-1 (PD-1) in Sezary Syndrome and Mycosis Fungoides, Archives of Dermatology -Chicago- 148(12): 1379-1385.
- Voskamp, P.; Bodmann, C.A.; Koehl, G.E.; Rebel, H.G.; Olderen, M.G.E. van; Gaumann, A.; Ghalbzouri, A. el; Tensen, C.P.; Bavinck, J.N.B.; Willemze, R.; Geissler, E.K. & Gruijl, F.R. de (2012), Dietary immunosuppressants do not enhance UV-induced skin carcinogenesis, and reveal discordance between p53-mutant early clones and carcinomas., Cancer Prevention Research.
- Cetinozman, F.; Jansen, P.M.; Vermeer, M.H. & Willemze, R. (2012), Sezary syndrome and mycosis fungoides show differential expression of programmed death-1, Journal of Investigative Dermatology 132: S40-S40.
- Thakoersing, V.S.; Smeden, J. van; Mulder, A.A.; Vreeken, R.J.; Ghalbzouri, A. el & Bouwstra, J.A. (2012), Increased Presence of Monounsaturated Fatty Acids in the Stratum Corneum of Human Skin Equivalents.
- Qin, Y.; Beurmans, H.P.J.; Kester, M.S. van; Fits, L. van der; Out-Luiting, J.J.; Osanto, S.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2012), microRNA deep sequencing in Sezary Syndrome reveals upregulation of miR-199a2/miR-214 cluster derived from the DNM3os transcript, Journal of Investigative Dermatology 131: S63S63.
- Hogewoning, A.A.; Bavinck, J.N.B.; Amoah, A.S.; Boakye, D.A.; Yazdanbakhsh, M.; Kremsner, P.G.; Adegnika, A.A.; Smedt, S.K.A.D. de; Willemze, R. & Lavrijsen, A.P.M. (2012), Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda, Journal of the European Academy of Dermatology and Venereology 26(4): 488-494.
- Fits, L. van der; Out-Luiting, J.J.; Leeuwen, M.A. van; Samsom, J.N.; Willemze, R.; Tensen, C.P. & Vermeer, M.H. (2012), Autocrine IL-21 Stimulation Is Involved in the Maintenance of Constitutive STAT3 Activation in Sezary Syndrome, Journal of Investigative Dermatology 132(2): 440-447.
- Fits, L. van der; Rebel, H.; Pouw, S.; Out-Luiting, J.; Zijl, L. van; Willemze, R.; Tensen, C.; Weijer, K. & Verneer, M. (2011), Immunodeficient mice as recipients for Sezary cells allow functional studies into the pathogenesis of Sezary Syndrome, Journal of Investigative Dermatology 131: S21S21.
- Wisgerhof, H.C.; Geest, L.G.M. van der; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Cessie, S. le; Willemze, R. & Bavinck, J.N.B. (2011), Incidence of cancer in kidney-transplant recipients: A long-term cohort study in a single center, Cancer Epidemiology 35(2): 105-111.
- Willemze, R. (2011), Update Mycosis Fungoides 2011, JDDG 9: 57-57.
- Janson, D.; Rietveld, M.; Willemze, R. & Ghalbzouri, A. el (2011), Replicative senescent fibroblasts alter the collagen metabolism in fibroblast-derived-matrix skin equivalents, Journal of Investigative Dermatology 131: S32S32.
- Kempf, W.; Pfaltz, K.; Vermeer, M.H.; Cozzio, A.; Ortiz-Romero, P.L.; Bagot, M.; Olsen, E.; Kim, Y.H.; Dummer, R.; Pimpinelli, N.; Whittaker, S.; Hodak, E.; Cerroni, L.; Berti, E.; Horwitz, S.; Prince, H.M.; Guitart, J.; Estrach, T.; Sanches, J.A.; Duvic, M.; Ranki, A.; Dreno, B.; Ostheeren-Michaelis, S.; Knobler, R.; Wood, G. & Willemze, R. (2011), EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma, Blood 118(15): 4024-4035.
- Commandeur, S.; Ho, S.H.; Gruijl, F.R. de; Willemze, R.; Tensen, C.P. & Ghalbzouri, A. el (2011), Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma, Experimental Dermatology 20(9): 737-742.
- Willemze, R. (2011), Primary cutaneous lymphomas, Annals of Oncology 22: 72-75.
- Hogewoning, A.A.; Adegnika, A.A.; Bavinck, J.N.B.; Yazdanbakhsh, M.; Kremsner, P.G.; Raaij-Helmer, E.M.H. van der; Staats, C.C.G.; Willemze, R. & Lavrijsen, A.P.M. (2011), Prevalence and causative fungal species of tinea capitis among schoolchildren in Gabon, Mycoses 54(5): E354E359.
- Qin, Y.; Verdegaal, E.M.E.; Siderius, M.; Bebelman, J.P.; Smit, M.J.; Leurs, R.; Willemze, R.; Tensen, C.P. & Osanto, S. (2011), Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target., Pigment Cell and Melanoma Research 24(1): 207-18.
- Olsen, E.A.; Whittaker, S.; Kim, Y.H.; Duvic, M.; Prince, H.M.; Lessin, S.R.; Wood, G.S.; Willemze, R.; Demierre, M.F.; Pimpinelli, N.; Bernengo, M.G.; Ortiz-Romero, P.L.; Bagot, M.; Estrach, T.; Guitart, J.; Knobler, R.; Sanches, J.A.; Iwatsuki, K.; Sugaya, M.; Dummer, R.; Pittelkow, M.; Hoppe, R.; Parker, S.; Geskin, L.; Pinter-Brown, L.; Girardi, M.; Burg, G.; Ranki, A.; Vermeer, M.; Horwitz, S.; Heald, P.; Rosen, S.; Cerroni, L.; Dreno, B. & Vonderheid, E.C. (2011), Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer, Journal of Clinical Oncology 29(18): 2598-2607.
- Benner, M.F.; Jansen, P.M.; Vermeer, M.H. & Willemze, R. (2011), Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases., Blood.
- Willemze, R.; Dreyling, M. & ESMO Guidelines Working Grp (2010), Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 21: v177v180.
- Wisgerhof, H.C.; Edelbroek, J.R.J.; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Willemze, R. & Bavinck, J.N.B. (2010), Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors, Transplantation 89(10): 1231-1238.
- Koens, L.; Vermeer, M.H.; Willemze, R. & Jansen, P.M. (2010), IgM Expression on Paraffin Sections Distinguishes Primary Cutaneous Large B-cell Lymphoma, Leg Type From Primary Cutaneous Follicle Center Lymphoma, American Journal of Surgical Pathology 34(7): 1043-1048.
- Wisgerhof, H.C.; Edelbroek, J.R.J.; Fijter, J.W. de; Feltkamp, M.C.W.; Willemze, R. & Bavinck, J.N.B. (2010), Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006, British Journal of Dermatology 162(2): 390-396.
- Kester, M.S. van; Tensen, C.P.; Vermeer, M.H.; Dijkman, R.; Mulder, A.A.; Szuhai, K.; Willemze, R. & Doorn, R. van (2010), Cutaneous Anaplastic Large Cell Lymphoma and Peripheral T-Cell Lymphoma NOS Show Distinct Chromosomal Alterations and Differential Expression of Chemokine Receptors and Apoptosis Regulators, Journal of Investigative Dermatology 130(2): 563-575.
- Hezewijk, M. van; Creutzberg, C.L.; Putter, H.; Chin, A.; Schneider, I.; Hoogeveen, M.; Willemze, R. & Marijnen, C.A.M. (2010), Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases, Radiotherapy and Oncology 95(2): 245-249.
- Wisgerhof HC, van der Boog PJ, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FH, Willemze R & Bouwes Bavinck JN (2009), Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
- Willemze R (2009), S11-dernatological oncology: lymphoma, JDDG 7: 48-48.
- Willemze R & Dreyling M (2009), Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up, Annals of Oncology 20: 115-118.
- Commandeur S, de Gruijl FR, Willemze R, Tensen CP & El Ghalbzouri A (2009), An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma, Experimental Dermatology 18(10): 849-856.
- van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, Knijnenburg J, Boer JM, Willemze R & Tensen CP (2009), Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome, Blood 113(1): 127-136.
- Hogewoning AA, Koelemij I, Amoah AS, Bavinck JNB, Aryeetey Y, Hartgers F, Yazdanbakhsh M, Willemze R, Boakye DA & Lavrijsen APM (2009), Prevalence and risk factors of inflammatory acne vulgaris in rural and urban Ghanaian schoolchildren, British Journal of Dermatology 161(2): 475-477.
- Commandeur S, de Gruijl FR, Willemze R, Tensen CP & El Ghalbzouri A (2009), An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma., Experimental Dermatology 18(10): 849-56.
- Benner MF & Willemze R (2009), Applicability and Prognostic Value of the New TNM Classification System in 135 Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma, Archives of Dermatology -Chicago- 145(12): 1399-1404.
- Wisgerhof HC, Hameetman L, Tensen CP, Morreau H, de Fijter JW, Bavinck JNB, Willemze R & de Gruijl FR (2009), Azathioprine-Induced Microsatellite Instability Is Not Observed in Skin Carcinomas of Organ Transplant Recipients, Journal of Investigative Dermatology 129(5): 1307-1309.
- Commandeur S, De Gruijl FR, Willemze R, Tensen CP & Elghalbzouri A (2009), Tumor-stroma interaction is essential in a primary human in vitro skin cancer model using a human cancer-associated dermal microenvironment, Journal of Investigative Dermatology 129: S71S71.
- Benner MF, Jansen PM, Meijer CJLM & Willemze R (2009), Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders, British Journal of Dermatology 161(1): 121-127.
- Neelis, K.J.; Schimmel, E.C.; Vermeer, M.H.; Senff, N.J.; Willemze, R. & Noordijk, E.M. (2009), LOW-DOSE PALLIATIVE RADIOTHERAPY FOR CUTANEOUS B- AND T-CELL LYMPHOMAS, International Journal of Radiation Oncology - Biology - Physics 74(1): 154-158.
- El Ghalbzouri A, Commandeur S, Rietveld MH, Mulder AA & Willemze R (2009), Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products, Biomaterials 30(1): 71-78.
- Wisgerhof HC, van der Boog PJM, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FHJ, Willemze R & Bavinck JNB (2009), Increased Risk of Squamous-Cell Carcinoma in Simultaneous Pancreas Kidney Transplant Recipients Compared with Kidney Transplant Recipients, Journal of Investigative Dermatology 129(12): 2886-2894.
- Willemze R, Dreyling M & ESMO Guidelines Working Group (2009), Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
- van Hezewijk M, Creutzberg CL, Putter H, Chin A, Willemze R & Marijnen CAM (2009), Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases, EJC Supplements 7(2): 584-584.
- van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, Knijnenburg J, Boer JM, Willemze R & Tensen CP (2009), Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome., Blood 113(1): 127-36.
- Koens L, Senff NJ, Vermeer MH, Ronday HK, Willemze R & Jansen PM (2009), Cutaneous Gamma/Delta T-cell Lymphoma During Treatment with Etanercept for Rheumatoid Arthritis, Acta Dermato-Venereologica 89(6): 653-654.
- Janssens AS, Pavel S, Tensen CP, Teunissen MBM, Out-Luiting JJ, Willemze R & de Gruijl FR (2009), Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption, Experimental Dermatology 18(3): 212-217.
- van Kester MS, Tensen CP, Vermeer MH, Dijkman R, Mulder AA, Szuhai K, Willemze R & van Doorn R (2009), Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators, Journal of Investigative Dermatology 129: S49S49.
- Senff NJ, Zoutman WH, Vermeer MH, Assaf C, Berti E, Cerroni L, Espinet B, Cabrera RFD, Geerts ML, Kempf W, Mitchell TJ, Paulli M, Petrella T, Pimpinelli N, Santucci M, Whittaker SJ, Willemze R & Tensen CP (2009), Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Journal of Investigative Dermatology 129(5): 1149-1155.
- van Galen JC, Hoefnagel JJ, Vermeer MH, Willemze R, Dijkman R, Tensen CP, de Boer W, Meijer CJ & Oudejans JJ (2008), Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma, Journal of Pathology 215(3).
- de Graaf YG, Rebel H, Elghalbzouri A, Cramers P, Nellen RG, Willemze R, Bouwes Bavinck JN & de Gruijl FR (2008), More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine., Experimental Dermatology 17(4): 349-55.
- Hameetman L, Wisgerhof HC, Tensen CP, Morreau H, Bavinck JNB, Willemze R & de Gruijl FR (2008), Azathioprine-induced microsatellite instability is not seen in cutaneous squamous cell carcinomas, Journal of Investigative Dermatology 128.
- Vermeer M, van Kesler MS, Borne PVD, Out-Luiting CJ, Willemze R & Tensen KP (2008), Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells, Journal of Investigative Dermatology 128.
- Iakovidou J, Gavressea T, Maltezas D, Repoussis P, Tzaida O & Willemze R (2008), Panniculitis-like T-cell lymphoma: a case report, Histopathology 53: 229-229.
- Wisgerhoi HC, de Fijter JW, Claas FH, Willemze R & Bavinck JNB (2008), Immunosuppression with rnycofenolatemofetil in stead of azathioprine significantly reduces the risk of skin cancer in kidney transplant recipients, Journal of Investigative Dermatology 128.
- de Snoo FA, Hottenga JJ, Gillanders EM, Sandkuijl LA, Jones MP, Bergman W, van der Drift C, van Leeuwen I, van Mourik L, ter Huurne JAC, Frants RR, Willemze R, Breuning MH, Trent JM & Gruis NA (2008), Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families, European Journal of Human Genetics 16(9).
- van Galen JC, Hoefnagel JJ, Vermeer MH, Willemze R, Dijkman R, Tensen CP, de Boer WP, Meijer CJ & Oudejans JJ (2008), Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma., Journal of Pathology 215(3): 340-6.
- El Ghalbzouri A, Siamari R, Willemze R & Ponec M (2008), Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines, Toxicology in Vitro 22(5).
- Senff NJ, Kluin-Nelemans HC & Willemze R (2008), Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma, British Journal of Haematology 142(1).
- Kempf W, Ostheeren-Michaelis S, Paulli M, Lucioni M, Wechsler J, Audring H, Assaf C, Rudiger T, Willemze R, Meijer CJLM, Berti E, Cerroni L, Santucci M, Hallermann C, Berneburg M, Chimenti S, Robson A, Marschalko M, Kazakov DV, Petrella T, Fraitag S, Carlotti A, Courville P, Laeng H, Knobler R, Golling P, Dummer R & Burg G (2008), Granulomatous Mycosis Fungoides and Granulomatous Slack Skin A Multicenter Study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC), Archives of Dermatology -Chicago- 144(12): 1609-1617.
- de Graaf YGL, Rebel H, Elghalbzouri A, Cramers P, Nellen RGL, Willemze R, Bavinck JNB & de Gruijl FR (2008), More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine, Experimental Dermatology 17(4).
- Hartmann TB, Mattern E, Wiedemann N, van Doorn R, Willemze R, Niikura T, Hildenbrand R, Schadendorf D & Eichmuller SB (2008), Identification of selectively expressed genes and antigens in CTCL, Experimental Dermatology 17(4).
- Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L, Dummer R, Duvic M, Hoppe RT, Pimpinelli N, Rosen ST, Vermeer MH, Whittaker S & Willemze R (2008), European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas, Blood 112(5).
- Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, Vader PCVV, Gerritsen MJP, Geerts ML, Gellrich S, Soderberg O, Leuchowius KJ, Landegren U, Out-Luiting JJ, Knijnenburg J, Ijszenga M, Szuhai K, Willemze R & Tensen CP (2008), Novel and highly recurrent chromosomal alterations in Sezary syndrome, Cancer Research 68(8).
- Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Dijk MRCV, Carlotti A, Geerts ML, Hahtola S, Hummel M, Jeskanen L, Kempf W, Massone C, Ortiz-Romero PL, Paulli M, Petrella T, Ranki A, Peralto JLR, Robson A, Senff NJ, Vermeer MH, Wechsler J, Whittaker S & Meijer CJLM (2008), Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases, Blood 111(2).
- van Kester MS, Out-Luiting JJ, von dem Borne PA, Willemze R, Tensen CP & Vermeer MH (2008), Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells, Journal of Investigative Dermatology 128(7).
- de Snoo FA, Bishop DT, Bergman W, van Leeuwen I, van der Drift C, van Nieuwpoort FA, Out-Luiting CJ, Vasen HF, ter Huurne JAC, Frants RR, Willemze R, Breuning MH & Gruis NA (2008), Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families, Clinical Cancer Research 14(21).
- Benner MF & Willemze R (2008), Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients, British Journal of Dermatology 159(5).
- van Maldegem F, van Dijk R, Wormhoudt TAM, Kluin PM, Willemze R, Cerroni L, van Noesel CJM & Bende RJ (2008), The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment, Blood 112(8).
- Wisgerhof HC, de Fijter JW, Claas FHJ, Willemze R & Bavinck JNB (2008), Patients with an increased number of kidney grafts have a decreased risk to develop squamous-cell carcinoma after transplantation, Journal of Investigative Dermatology 128(10).
- Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH, Willemze R, van Doorn R, Tensen CP, Young BD & Whittaker SJ (2008), A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS, Journal of Cutaneous Pathology 35(10).
- Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH & Tensen CP (2007), Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities., Blood 109(4): 1720-7.
- Dijkman R, Tensen CP, Jordanova ES, Knijnenburg J, Hoefnagel JJ, Mulder AA, Rosenberg C, Raap AK, Willemze R, Szuhai K & Vermeer MH (2006), Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma., Journal of Clinical Oncology 24(2): 296-305.
- Dijkman R, Tensen CP, Buettner M, Niedobitek G, Willemze R & Vermeer MH (2006), Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID., Blood 107(12): 4926-9.
- Senff NJ, Vermeer MH, Hoefnagel JJ, Jansen PM, Meijer CJ & Willemze R (2006), Reclassification of 299 primary cutaneous B-cell lymphoma according to the new WHO-EORTC classification for cutaneous lymphomas and characterization of prognostic parameters, Journal of Investigative Dermatology 126: 116-116.
- Dijkman, R.; Doorn, R. van; Szuhai, K.; Willemze, R.; Vermeer, M.H. & Tensen, C.P. (2006), Integrated genomic analysis classify CD4+CD56+hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities and reveal novel diagnostic and therapeutic targets, Journal of Investigative Dermatology 126: 41-41.
- Dijkman R, Szuhai K, Knijnenburg J, Jordanova E, Willemze R, Vermeer M & Tensen C (2005), Array CGH analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma, Journal of Investigative Dermatology 125(3): A69A69.
- Doorn, R. van; Dijkman, R.; Vermeer, M.H.; Out-Luiting, J.J.; Raaij-Helmer, E.M.H. van der; Willemze, R. & Tensen, C.P. (2004), Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis, Cancer Research 64(16): 5578-5586.
- lid van wetenschappelijke raad
- Lid
- lid van wetenschappelijke raad